Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis1 passage
• Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial1 passage
• Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis1 passage
• Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout1 passage
• Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study1 passage
• Improving outcomes for patients hospitalized with gout: a systematic review1 passage
• Incidence and risk of nephrolithiasis with uricosuric therapies for the treatment of gout: a systematic review and meta-analysis of randomized controlled trials and cohort studies1 passage
• Initiation of febuxostat for acute gout flare does not prolong the current episode: a randomized clinical trial1 passage
• Intercritical circulating levels of neo-epitopes reflecting matrixmetalloprotease-driven degradation as markers of gout and frequent gout attacks1 passage
• Lack of effect of tart cherry concentrate dose on serum urate in people with gout1 passage
• Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis1 passage
• Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis1 passage
• Pharmacological interventions for early-stage frozen shoulder: a systematic review and network meta-analysis1 passage
• Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events1 passage
• Targeting neurotrophic factors for low back pain and sciatica: a systematic review and meta-analysis1 passage
• The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus25 passages
• The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout1 passage
• The diagnostic performance of dual energy CT for diagnosing gout: a systematic literature review and meta-analysis1 passage
• Time-varying cardiovascular risk of febuxostat vs. allopurinol in gout: a one-stage meta-analysis1 passage
• Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis1 passage